182 related articles for article (PubMed ID: 11118440)
1. Differential association of products of alternative transcripts of the candidate tumor suppressor ING1 with the mSin3/HDAC1 transcriptional corepressor complex.
Skowyra D; Zeremski M; Neznanov N; Li M; Choi Y; Uesugi M; Hauser CA; Gu W; Gudkov AV; Qin J
J Biol Chem; 2001 Mar; 276(12):8734-9. PubMed ID: 11118440
[TBL] [Abstract][Full Text] [Related]
2. Role of the Sin3-histone deacetylase complex in growth regulation by the candidate tumor suppressor p33(ING1).
Kuzmichev A; Zhang Y; Erdjument-Bromage H; Tempst P; Reinberg D
Mol Cell Biol; 2002 Feb; 22(3):835-48. PubMed ID: 11784859
[TBL] [Abstract][Full Text] [Related]
3. [Effects of two variants of ING1 expression on tumor cell growth regulation].
Liu JY; Wu BQ; Zheng J; You JF; Zhong HH; Wang JL
Zhonghua Bing Li Xue Za Zhi; 2003 Feb; 32(1):48-51. PubMed ID: 12760804
[TBL] [Abstract][Full Text] [Related]
4. Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent manner.
Zhu Z; Luo Z; Li Y; Ni C; Li H; Zhu M
Hepatology; 2009 Feb; 49(2):504-12. PubMed ID: 19085961
[TBL] [Abstract][Full Text] [Related]
5. p24/ING1-ALT1 and p47/ING1-ALT2, distinct alternative transcripts of p33/ING1.
Saito A; Furukawa T; Fukushige S; Koyama S; Hoshi M; Hayashi Y; Horii A
J Hum Genet; 2000; 45(3):177-81. PubMed ID: 10807544
[TBL] [Abstract][Full Text] [Related]
6. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
7. Human ING1 proteins differentially regulate histone acetylation.
Vieyra D; Loewith R; Scott M; Bonnefin P; Boisvert FM; Cheema P; Pastyryeva S; Meijer M; Johnston RN; Bazett-Jones DP; McMahon S; Cole MD; Young D; Riabowol K
J Biol Chem; 2002 Aug; 277(33):29832-9. PubMed ID: 12015309
[TBL] [Abstract][Full Text] [Related]
8. p33(ING1b) stimulates the transcriptional activity of the estrogen receptor alpha via its activation function (AF) 2 domain.
Toyama T; Iwase H; Yamashita H; Hara Y; Sugiura H; Zhang Z; Fukai I; Miura Y; Riabowol K; Fujii Y
J Steroid Biochem Mol Biol; 2003 Oct; 87(1):57-63. PubMed ID: 14630091
[TBL] [Abstract][Full Text] [Related]
9. Relative levels of alternative transcripts of the ING1 gene and lack of mutations of p33/ING1 in haematological malignancies.
Bromidge T; Lynas C
Leuk Res; 2002 Jul; 26(7):631-5. PubMed ID: 12008079
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel BRMS1-homologue protein p40 as a component of the mSin3A/p33(ING1b)/HDAC1 deacetylase complex.
Nikolaev AY; Papanikolaou NA; Li M; Qin J; Gu W
Biochem Biophys Res Commun; 2004 Oct; 323(4):1216-22. PubMed ID: 15451426
[TBL] [Abstract][Full Text] [Related]
11. Identification of the p33(ING1)-regulated genes that include cyclin B1 and proto-oncogene DEK by using cDNA microarray in a mouse mammary epithelial cell line NMuMG.
Takahashi M; Seki N; Ozaki T; Kato M; Kuno T; Nakagawa T; Watanabe K; Miyazaki K; Ohira M; Hayashi S; Hosoda M; Tokita H; Mizuguchi H; Hayakawa T; Todo S; Nakagawara A
Cancer Res; 2002 Apr; 62(8):2203-9. PubMed ID: 11956069
[TBL] [Abstract][Full Text] [Related]
12. ING1 and p53 tumor suppressor gene alterations in adenocarcinomas of the esophagogastric junction.
Hara Y; Zheng Z; Evans SC; Malatjalian D; Riddell DC; Guernsey DL; Wang LD; Riabowol K; Casson AG
Cancer Lett; 2003 Mar; 192(1):109-16. PubMed ID: 12637159
[TBL] [Abstract][Full Text] [Related]
13. Structure and regulation of the mouse ing1 gene. Three alternative transcripts encode two phd finger proteins that have opposite effects on p53 function.
Zeremski M; Hill JE; Kwek SS; Grigorian IA; Gurova KV; Garkavtsev IV; Diatchenko L; Koonin EV; Gudkov AV
J Biol Chem; 1999 Nov; 274(45):32172-81. PubMed ID: 10542254
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of p33(ING1) and the relationship with p53 expression in human gastric cancer.
Oki E; Maehara Y; Tokunaga E; Kakeji Y; Sugimachi K
Cancer Lett; 1999 Dec; 147(1-2):157-62. PubMed ID: 10660101
[TBL] [Abstract][Full Text] [Related]
15. ING1 isoforms differentially affect apoptosis in a cell age-dependent manner.
Vieyra D; Toyama T; Hara Y; Boland D; Johnston R; Riabowol K
Cancer Res; 2002 Aug; 62(15):4445-52. PubMed ID: 12154053
[TBL] [Abstract][Full Text] [Related]
16. Comparative assessment expression of the inhibitor of growth 1 gene (ING1) in normal and neoplastic tissues.
Nouman GS; Angus B; Lunec J; Crosier S; Lodge A; Anderson JJ
Hybrid Hybridomics; 2002 Feb; 21(1):1-10. PubMed ID: 11991811
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of nuclear expression of the p33(ING1b) inhibitor of growth protein in invasive carcinoma of the breast.
Nouman GS; Anderson JJ; Crosier S; Shrimankar J; Lunec J; Angus B
J Clin Pathol; 2003 Jul; 56(7):507-11. PubMed ID: 12835295
[TBL] [Abstract][Full Text] [Related]
18. Expression and sequence analyses of p33(ING1) gene in myeloid leukemia.
Ito K; Kinjo K; Nakazato T; Ikeda Y; Kizaki M
Am J Hematol; 2002 Feb; 69(2):141-3. PubMed ID: 11835353
[TBL] [Abstract][Full Text] [Related]
19. Generation of a polyclonal antibody specifically against the p33(ING1b) tumor suppressor.
Campos EI; Xiao H; Li G
J Immunoassay Immunochem; 2004; 25(1):71-80. PubMed ID: 15038618
[TBL] [Abstract][Full Text] [Related]
20. Three yeast proteins related to the human candidate tumor suppressor p33(ING1) are associated with histone acetyltransferase activities.
Loewith R; Meijer M; Lees-Miller SP; Riabowol K; Young D
Mol Cell Biol; 2000 Jun; 20(11):3807-16. PubMed ID: 10805724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
